Alteration of methotrexate metabolism in rats by administration of an elemental liquid diet I. Changes in drug enterohepatic circulation

Cancer

Volumn 59, Issue 1, 1987, Pages 31-37

  McAnena, Oliver J ^a   Rossi, Michelle ^a   Mehta, Bipn M ^a   Daly, John M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; RADIOISOTOPE;

ADVERSE DRUG REACTION; ANIMAL EXPERIMENT; DIET; DIGESTIVE SYSTEM; DOSE RESPONSE; DRUG METABOLISM; DRUG RESPONSE; DRUG TOXICITY; ENTERITIS; ENTEROHEPATIC CIRCULATION; GASTROINTESTINAL TOXICITY; INTESTINE MUCOSA; INTOXICATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; METHOTREXATE H 3; NONHUMAN; PHARMACOKINETICS; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; RAT; SMALL INTESTINE;

ANIMAL; BILE; DIET; FOOD, FORMULATED; INTESTINE, SMALL; KINETICS; LIVER; MALE; METHOTREXATE; PORTAL VEIN; RATS; RATS, INBRED F344; VENA CAVA, INFERIOR;

EID: 0023089468     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19870101)59:1<31::AID-CNCR2820590111>3.0.CO;2-G     Document Type: Article

References (39)

1. A dietary approach to the prevention and management of gastrointestinal complications of shock, cancer chemotherapy and irradiation
2. Test dose for predicting high‐dose methotrexate infusions
3. The use of enteral nutrition in the patient with cancer
4. Home management of nutrition for patients receiving cancer therapy
5. Protection by an elemental diet against the toxic intestinal changes of 5‐fluorouracil in rats
6. Use of an elemental diet in animals during treatment with 5‐fluorouracil
7. Elemental diet in the management of the intestinal lesion produced by 5‐fluorouracil in the rat
8. Elemental diet in the management of the intestinal lesion produced by 5‐fluorouracil in man
9. The use of elemental diets during cancer therapy
10. The adverse effects of elemental diets on tolerance for 5‐fluorouracil toxicity in the rat
11. Enhanced 5‐fluorouracil mortality in rats eating defined formula diets
12. Can elemental diets reduce the intestinal toxicity of 5‐fluorouracil?
13. Alteration of methotrexate pharmacokinetics and host toxicosis in rats by dietary manipulation
14. Alteration of chemotherapy toxicity using a chemically defined liquid diet in rats
15. Toxicity and metabolism of drugs in relation to dietary protein
16. The influence of diets containing from 1 to 81 percent protein on tolerated doses of pesticides
17. Dietary fatty acid‐induced alterations of hepatic microsomal drug metabolism
18. Significance of the 48‐hour plasma level in high‐dose methotrexate regimens
19. Enterohepatic circulation of methotrexate in rats in vivo
20. The pharmacology and clinical use of methotrexate
21. Increased mucosal damage during parasite infection in mice fed an elemental diet
22. Folic acid derivatives synthesized during growth of diplococcus pneumoniae
23. Homogeneous enzyme immunoassay: A new immunochemical technique
24. Small intestinal and colonic changes induced by a chemically defined diet
25. Pancreatic pathology, chemically defined liquid diets and bacterial flora in the rat
26. A pH dependent, carrier mediated transport system for the folate analogue, amethopterin, in the rat jejunum
27. Effects of “elemental” diets on absorptive and enzymatic activities and on 5‐fluorouracil toxicity in rat small intestine
28. Effect of malnutrition on methotrexate toxicity and tissue levels of dihydrofolate reductase in the rat
29. Effect of chronic parenteral carbohydrate administration on hepatic drug metabolism in the rat
30. A study of some possible mechanisms by which glucose inhibits drug metabolism in vivo and in vitro
31. Interactions between nutritional factors and drug biotransformations in man
32. Effect of dietary fats on pentobarbitone induced sleeping times and hepatic microsomal cytochrome p‐450 in rats
33. Mechanism of action of methotrexate. IV. Free intracellular methotrexate required to suppress dihydrofolate reduction to tetrahydrofolate by Ehrlich ascites tumor cells in vitro
34. Analysis of the role of membrane transport and polyglutamylation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity
35. Progress report: Elemental diets
36. New approaches to cancer chemotherapy with methotrexate
37. Alteration of methotrexate plasma pharmacokinetics by dietary manipulation
38. Reduction of methotrexate toxicity with improved nutritional status